The largest community for pharma industry

COVID-19

Oragenics Provides Update on SARS-CoV-2 (COVID-19) Program

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or “the Company”) today provided an update on progress with its SARS-CoV-2 (COVID-19) vaccine candidate and...

Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-19

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced additional data on remdesivir, an investigational antiviral for the treatment of COVID-19, adding to...

Applied DNA Forms Clinical Testing Subsidiary to Maximize Utility of FDA EUA-Approved Linea™ COVID-19 Assay Kit and Expands Utility with Successful EUA Amendment

STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that...

ChromaDex Announces New Study Results Highlighting Promising Anti-Viral Effects of Niagen® in Coronavirus Cell Model

LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC) today announced the latest preclinical findings indicating Niagen® (patented nicotinamide riboside) inhibits replication of a form of Coronavirus, the...

Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate

CAMBRIDGE, Mass. & MADRID--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new...

Biorasi Kicks-Off Third COVID-19 Clinical Trial for 2020

MIAMI--(BUSINESS WIRE)--Biorasi, a leading global full-service contract research organization (CRO), has announced the start of the company’s third COVID-19 clinical trial for 2020. Taking...

Ridgeback Biotherapeutics Announces Potential COVID-19 Treatment EIDD-2801 Will Leverage Innovative Testing Platform AGILE for Phase 2 Trial

MIAMI--(BUSINESS WIRE)--Ridgeback Biotherapeutics announces the start of enrollment in a Phase 2 trial of potential COVID-19 treatment EIDD-2801. The new trial will be conducted...

CEPI Expands Partnership with Clover Biopharmaceuticals to Rapidly Advance Development and Manufacture of COVID-19 Vaccine Candidate

OSLO, Norway--(BUSINESS WIRE)--CEPI, the Coalition for Epidemic Preparedness Innovations, today announced the expansion of its partnership with Sichuan Clover Biopharmaceuticals, Inc (China) (“Clover”) to...

Gilead Sciences Presents Survey Findings on PrEP Access and Utilization in the U.S. During COVID-19 Shelter-in-Place Orders

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced data presented at the 23rd International AIDS Conference (AIDS 2020: Virtual) evaluating the impact...

Osivax Receives Over EUR 30M in Public Funding to Support Development of Universal Coronavirus & Influenza Vaccines

LYON, France--(BUSINESS WIRE)--Osivax announced today that it has received over EUR 30M in public funding from different sources to support the development of universal...

Medidata Partners With CTI for Remote Source Review of Clinical Trials in Response to COVID-19

NEW YORK--(BUSINESS WIRE)--Medidata, the global leader in creating end-to-end solutions to support the entire clinical trial process, and a Dassault Systèmes company, announced that...

Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of...

Recent Featured Articles

Eurofins Publishes Robust Method to Analyse SARS-CoV-2 in Wastewater Samples, Providing Early Warning of Potential COVID-19 Outbreak at a Given Site

LUXEMBOURG--(BUSINESS WIRE)--A study undertaken by Eurofins scientists has resulted in a robust method to analyse SARS-CoV-2 in wastewater samples, allowing for early detection of...

NICE Partners with Flatiron Health to Develop Real-World Evidence Research Methodologies

MANCHESTER, England & NEW YORK--(BUSINESS WIRE)--The National Institute for Health and Care Excellence (NICE, www.nice.org.uk) is partnering with Flatiron Health (www.flatiron.com), an oncology research...

60 Degrees Pharmaceuticals Announces Positive Results of Cell Culture Testing of ARAKODA® (tafenoquine) for COVID-19

WASHINGTON--(BUSINESS WIRE)--60 Degrees Pharmaceuticals, LLC (60P), a pharmaceutical company focused on developing new medicines for tropical diseases, announced today that initial testing in cell...

Doctor Evidence to Deploy Its AI-Enabled SaaS DOC Search™ and DOC Analytics™ Platform for COVID-19 to Accelerate Drug Discovery

SANTA MONICA, Calif.--(BUSINESS WIRE)--Doctor Evidence (“DRE”) has developed new tools for automated network meta-analysis, to now be used in the hunt for the most...

Atlantic Therapeutics appoints Susan Trent as new CEO, based in the United States

GALWAY, Ireland--(BUSINESS WIRE)--Today Atlantic Therapeutics, a Galway-based MedTech and Femtech innovator, announces a transition in leadership to fulfill the potential of the INNOVO® brand...